Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation...
16 KB (1,367 words) - 23:56, 10 July 2024
DOACs are not as widely studied, idarucizumab (for dabigatran) and andexanet alfa (for factor Xa inhibitor) have been used in clinical settings with varying...
78 KB (8,755 words) - 00:46, 23 July 2024
asfotase alfa (Strensiq), used to treat hypophosphatasia; sebelipase alfa (Kanuma), used to treat lysosomal acid lipase deficiency, and andexanet alfa (Andexxa)...
20 KB (1,378 words) - 15:28, 5 August 2024
reuptake inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Andexanet alfa is a US Food and Drug Administration (FDA) approved antidote for apixaban...
25 KB (2,069 words) - 01:49, 1 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
22 KB (2,320 words) - 13:06, 15 August 2024
trials for andexanet alfa as an antidote for Factor Xa inhibitors with few adverse effects, and started Phase III trials. Andexanet alfa was approved...
29 KB (2,608 words) - 01:33, 1 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
24 KB (1,905 words) - 15:43, 27 August 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
31 KB (2,741 words) - 18:31, 9 August 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
41 KB (3,452 words) - 21:10, 4 September 2024
dabigatran (idarucizumab), and for apixaban, and rivaroxaban (andexanet alfa). Andexanet alfa is suggested for edoxaban, but use of it is considered off...
94 KB (9,772 words) - 05:31, 19 April 2024
authorisation for Andexanet alfa (in EU: Ondexxya). In April 2019 the European Commission granted the authorisation (approved) Andexanet for the 28 countries...
8 KB (637 words) - 15:06, 28 August 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
53 KB (4,947 words) - 11:31, 2 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
16 KB (1,231 words) - 04:59, 4 February 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
28 KB (2,718 words) - 01:28, 5 September 2024
antiplatelet medication. The specific reversal agents idarucizumab and andexanet alfa may be used to stop continued intracerebral hemorrhage in people taking...
44 KB (4,483 words) - 17:27, 12 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
10 KB (703 words) - 17:18, 20 April 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
42 KB (3,798 words) - 21:42, 30 August 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
10 KB (724 words) - 06:09, 16 July 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
24 KB (2,132 words) - 11:10, 7 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
56 KB (5,566 words) - 02:21, 16 August 2024
Hemodialysis does not significantly contribute to edoxaban clearance. Andexanet alfa has been studied as an antidote for edoxaban overdose, but has only...
14 KB (1,041 words) - 05:24, 7 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
41 KB (3,282 words) - 05:55, 27 May 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
5 KB (286 words) - 05:02, 7 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
14 KB (1,191 words) - 05:34, 18 July 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
9 KB (800 words) - 00:48, 28 October 2023
Arrillaga A, Caronia C, Rothburd L, Japhe T, Hahn Y, et al. (2024). "Use of Andexanet Alfa for Factor Xa Inhibitor Reversal in US Verified Trauma Centers: A National...
18 KB (1,479 words) - 06:45, 28 July 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
86 KB (7,963 words) - 18:33, 12 September 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
10 KB (832 words) - 04:43, 7 February 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
31 KB (2,634 words) - 22:05, 30 August 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
10 KB (799 words) - 13:28, 4 September 2024